| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.5M | +110.8% | — |
| R&D Expense | $19.8M | +22.2% | -58.5% |
| SG&A Expense | $12.3M | -4.2% | -31.9% |
| Operating Income | -$24.5M | +52.4% | +62.6% |
| Interest Expense | $2.4M | +18.8% | — |
| Net Income | -$25.1M | +52.8% | +59.6% |
| EPS (Basic) | -$0.28 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $165.6M | +19.6% | +72.9% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $8.1M | +1282.7% | +6352.4% |
| Current Assets | $176.9M | -3.2% | -34.8% |
| Total Assets | $201.8M | -4.2% | -38.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$128.9M | — | — |
| Capital Expenditures | $547K | — | — |
| Investing Cash Flow | $138.6M | — | — |
| Financing Cash Flow | $23.1M | — | — |
| Free Cash Flow | -$129.4M | — | — |
| +62.7% |
| EPS (Diluted) | -$0.28 | +55.6% | +62.7% |
| $61.8M |
| -6.3% |
| -14.6% |
| Long-term Debt | $54.1M | +4.6% | — |
| Total Liabilities | $188.3M | -1.6% | +23.9% |
| Stockholders' Equity | $13.5M | -29.9% | -92.3% |